“Adverse Drug Reactions: Issues and Challenges during Covid-19”
The School of Health Sciences, UPES organized a conference on ‘Adverse Drug Reactions: Issues and Challenges during Covid-19’, under the theme of Pharmacovigilance, in collaboration with the National Coordination Centre - Pharmacovigilance Programme of India (PvPI), Indian Pharmacopoeia Commission, and Ministry of Health and Family Welfare, Government of India, on 10th – 11th January 2022.
The theme of the conference was significant in the context of repercussions of adverse drug reactions in the raging COVID 19 pandemic and highlighted how crucially important it is to discuss and review the data that has been collected so far in India.
The Welcome Address was delivered by Dean, School of Health Sciences and Technology, Prof. Neeraj Mahendroo, followed by the address conferred by respected VC Sir, UPES, Dr. Sunil Rai, who emphasized the notion “Prevention is better than cure”, and how in the era of social network, it is so crucial to be aware, follow reliable sources and be logical in terms of drug use.
The gathering was addressed by several other dignitaries and speakers, including the Keynote Address delivered by internationally acclaimed Dr. Y. K Gupta, President of AIIMS Bhopal & Jammu. The inaugural address was conferred by the respected Chief Guest, Dr. Rajendra Dobhal, Director General, Uttarakhand State Council of Science and Technology, GOI. He shared his insights and experiences on pharmacovigilance, precisely in post-COVID scenarios, and aftereffects of the vaccination.
The two-day conference was broken down into 5 informative sessions, focusing on several topics, including alternative systems of medicines, challenges in vaccine development, self-medication, herbal drugs and many more eye-opening themes.
At the closing of the event, Dr. Veena Dutta, Registrar UPES attended and addressed the valedictory ceremony. The event was a remarkable success, highlighting UPES’s commitment to contribute to the development of individuals who can be active change-makers and solution providers for the healthcare sector.